Shreehas Tambe appointed as new chairman of CII's National Pharmaceutical Committee
Amitabh Dube and Sheetal Arora named Co-Chairmen for the forthcoming term
Amitabh Dube and Sheetal Arora named Co-Chairmen for the forthcoming term
Ranluspec is the only interchangeable ranibizumab biosimilar approved in the United States in both vial and pre-filled syringe (PFS) presentations
Teva said the launch strengthens its biosimilars strategy and expands access to biologic medicines across Europe
Industry body aims to strengthen policy advocacy, innovation, and global competitiveness of India's fast-growing CRDMO sector
Dr. Rishi brings more than 15 years of experience in bioprocess development, microbial fermentation, technology transfer, and biotechnology operations
Novel fluorescent nanosensor enables real-time detection of indole-3-propionic acid (IPA), paving the way for faster gut health screening, point-of-care diagnostics, and wearable monitoring devices
Anti-GD2 monoclonal antibody for high-risk neuroblastoma advances toward BLA submission following successful tech transfer from California to Bengaluru
We have the chance to build an IP estate that goes hand in hand with our generic pharmaceutical strength and build proprietary biological platforms
The conference highlighted research suggesting that deuterium levels may influence key biological processes
The approval marks a major milestone in the global fight against antimicrobial resistance
Subscribe To Our Newsletter & Stay Updated